Althea Group Holdings Ltd. (AU:PKP)
ASX:PKP
Want to see AU:PKP full AI Analyst Report?
Top Page
Althea Group Holdings Ltd.
(Sydney:PKP)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.02
Action:Upgraded
Date:03/24/26
The score is driven primarily by weak financial performance—sharp revenue contraction, ongoing losses, continued cash burn, and negative equity—followed by bearish technical signals (oversold RSI, negative MACD, and trading below the 200-day average). Valuation provides limited support because earnings are negative and no dividend yield is available.
Positive Factors
Improved gross margin
A sustained gross margin near 48% indicates stronger product economics and better cost of goods control or richer product mix. This helps absorb SG&A and supports a credible path to operating leverage over months if revenue stabilizes, making profitability achievable longer term.
Negative Factors
Sharp revenue decline
A steep revenue contraction materially weakens unit economics and hinders fixed cost absorption. Persisting top‑line declines reduce the likelihood of sustained profitability and lengthen the time needed to leverage improved gross margins into positive operating cash flow.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved gross margin
A sustained gross margin near 48% indicates stronger product economics and better cost of goods control or richer product mix. This helps absorb SG&A and supports a credible path to operating leverage over months if revenue stabilizes, making profitability achievable longer term.
Read all positive factors
Althea Group Holdings Ltd. (PKP) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$19.73M
Dividend YieldN/A
Average Volume (3M)1.24M
Price to Earnings (P/E)―
Beta (1Y)0.57
Revenue Growth-53.90%
EPS Growth57.52%
CountryAU
EmployeesN/A
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,160,605,600
10 Day Avg. Volume1,829,506
30 Day Avg. Volume1,236,918
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Althea Group Holdings Ltd. Business Overview & Revenue Model
Company Description
Peak Processing Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, va...
How the Company Makes Money
Althea Group Holdings Ltd. generates revenue predominantly through the sale of its medical cannabis products to patients via clinics, pharmacies, and healthcare providers. The company also earns income from its wholesale distribution of pharmaceut...
Althea Group Holdings Ltd. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
14
Very Negative
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Althea Group Holdings Ltd. Technical Analysis
―
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:PKP, the sentiment is undefined. The current price of undefined is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a undefined sentiment for AU:PKP.
Althea Group Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
Althea Group Holdings Ltd. Corporate Events
Peak Processing plans major share and option issue on ASX
May 4, 2026
Peak Processing Limited, listed on the ASX under the code PKP, is an Australian public company engaged in capital market activities through the issuance of ordinary equity and options. The specific industry focus and operating segments of the busi...
Peak Processing Raises A$2.4m to Fund Ramp‑Up in THC Beverage Production
May 1, 2026
Peak Processing Limited has secured binding commitments from sophisticated and professional investors to raise A$2.4 million via an unsecured loan note issue convertible at A$0.015 per share, subject to shareholder approval. The capital injection ...
Peak Processing Requests ASX Trading Halt Ahead of Capital Raise
Apr 29, 2026
Peak Processing Limited has requested a halt in trading of its quoted securities on the ASX as it prepares a market announcement tied to a proposed capital raising. The company has indicated it is not aware of any reasons the halt should be refuse...
Peak Processing turns EBITDA‑positive as reset drives production surge and major customer wins
Apr 29, 2026
Peak Processing has completed its operational reset, reporting its first month of positive EBITDA in March 2026, driven by record unaudited revenue of about A$1.2 million, a 56% contribution margin and substantially lower operating expenses. The b...
Althea Director Increases Indirect Stake in Peak Processing Limited
Mar 24, 2026
Peak Processing Limited, associated with cannabis and health products group Althea, operates in the processing and supply of regulated cannabis-derived products for medical and consumer-use markets. Its activities are aligned with providing compli...
Peak Processing issues new shares for consulting services under disclosure exemption
Mar 20, 2026
Peak Processing Limited has issued 1,714,117 ordinary shares at $0.017 per share to a sophisticated investor as payment for consulting services. The company stated that the shares were issued without a prospectus under the Corporations Act exempti...
Peak Processing issues new shares to service provider for ASX quotation
Mar 20, 2026
Peak Processing Limited has applied to the ASX for quotation of 1,714,117 new ordinary fully paid shares under the code PKP, issued on March 20, 2026. The shares were issued to a service provider as non-cash consideration for services rendered, in...
Althea’s Peak Processing to Lift Cannabis Beverage Output to 1.4 Million Units in Q4 FY26
Mar 16, 2026
Peak Processing Limited reported strong operational momentum in its Canadian cannabis beverage business, with quarterly production rising from 702,289 units in Q2 FY26 to an expected 900,000 units in Q3 and approximately 1.4 million units in Q4, d...
Peak Processing expands Sweet Justice deal, securing 1.4m-unit annual cannabis beverage output
Mar 2, 2026
Peak Processing Limited has renewed and expanded its manufacturing agreement with Electric Brands Inc., owner of the Sweet Justice cannabis beverage portfolio, reinforcing its role as a scaled producer in the regulated cannabis and hemp-derived dr...
Peak Processing completes strategic reset to focus on North American THC beverages
Feb 27, 2026
Peak Processing Limited has completed a strategic reset, exiting its legacy UK and Australian medical cannabis operations to concentrate on its North American THC beverage business. The company has overhauled its board and executive team, rebrande...
Peak Processing Flags Deeper Half-Year Loss and Going-Concern Risk Amid Restructuring
Feb 27, 2026
Peak Processing Limited reported a steep decline in revenue for the half year ended 31 December 2025, with ordinary activities income falling 47.7% to $5.49 million compared with the prior corresponding period. The group, which consolidates operat...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.